Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced the completion...